290 related articles for article (PubMed ID: 25217799)
21. Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib.
Kalykaki A; Agelaki S; Kallergi G; Xyrafas A; Mavroudis D; Georgoulias V
Cancer Chemother Pharmacol; 2014 Apr; 73(4):685-93. PubMed ID: 24493157
[TBL] [Abstract][Full Text] [Related]
22. Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients.
de Albuquerque A; Kubisch I; Ernst D; Breier G; Stamminger G; Fersis N; Stölzel U; Boese-Landgraf J; Eichler A; Kaul S
Clin Lab; 2012; 58(5-6):373-84. PubMed ID: 22783565
[TBL] [Abstract][Full Text] [Related]
23. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
[TBL] [Abstract][Full Text] [Related]
24. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.
Sieuwerts AM; Mostert B; Bolt-de Vries J; Peeters D; de Jongh FE; Stouthard JM; Dirix LY; van Dam PA; Van Galen A; de Weerd V; Kraan J; van der Spoel P; Ramírez-Moreno R; van Deurzen CH; Smid M; Yu JX; Jiang J; Wang Y; Gratama JW; Sleijfer S; Foekens JA; Martens JW
Clin Cancer Res; 2011 Jun; 17(11):3600-18. PubMed ID: 21505063
[TBL] [Abstract][Full Text] [Related]
25. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.
Mostert B; Kraan J; Bolt-de Vries J; van der Spoel P; Sieuwerts AM; Schutte M; Timmermans AM; Foekens R; Martens JW; Gratama JW; Foekens JA; Sleijfer S
Breast Cancer Res Treat; 2011 May; 127(1):33-41. PubMed ID: 20379845
[TBL] [Abstract][Full Text] [Related]
26. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
[TBL] [Abstract][Full Text] [Related]
27. Serum IGF-1, IGFBP-3 levels and circulating tumor cells (CTCs) in early breast cancer patients.
Papadakis GZ; Mavroudis D; Georgoulias V; Souglakos J; Alegakis AK; Samonis G; Bagci U; Makrigiannakis A; Zoras O
Growth Horm IGF Res; 2017 Apr; 33():28-34. PubMed ID: 28258988
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer.
Ignatiadis M; Kallergi G; Ntoulia M; Perraki M; Apostolaki S; Kafousi M; Chlouverakis G; Stathopoulos E; Lianidou E; Georgoulias V; Mavroudis D
Clin Cancer Res; 2008 May; 14(9):2593-600. PubMed ID: 18451221
[TBL] [Abstract][Full Text] [Related]
29. Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription-polymerase chain reaction for epidermal growth factor receptor.
Leitzel K; Lieu B; Curley E; Smith J; Chinchilli V; Rychlik W; Lipton A
Clin Cancer Res; 1998 Dec; 4(12):3037-43. PubMed ID: 9865918
[TBL] [Abstract][Full Text] [Related]
30. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
Cohen SJ; Alpaugh RK; Gross S; O'Hara SM; Smirnov DA; Terstappen LW; Allard WJ; Bilbee M; Cheng JD; Hoffman JP; Lewis NL; Pellegrino A; Rogatko A; Sigurdson E; Wang H; Watson JC; Weiner LM; Meropol NJ
Clin Colorectal Cancer; 2006 Jul; 6(2):125-32. PubMed ID: 16945168
[TBL] [Abstract][Full Text] [Related]
31. Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer.
Daskalaki A; Agelaki S; Perraki M; Apostolaki S; Xenidis N; Stathopoulos E; Kontopodis E; Hatzidaki D; Mavroudis D; Georgoulias V
Br J Cancer; 2009 Aug; 101(4):589-97. PubMed ID: 19623181
[TBL] [Abstract][Full Text] [Related]
32. Global gene expression profiling of circulating tumor cells.
Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
[TBL] [Abstract][Full Text] [Related]
33. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
Stathopoulou A; Gizi A; Perraki M; Apostolaki S; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
Clin Cancer Res; 2003 Nov; 9(14):5145-51. PubMed ID: 14613993
[TBL] [Abstract][Full Text] [Related]
34. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
35. HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.
Fehm T; Müller V; Aktas B; Janni W; Schneeweiss A; Stickeler E; Lattrich C; Löhberg CR; Solomayer E; Rack B; Riethdorf S; Klein C; Schindlbeck C; Brocker K; Kasimir-Bauer S; Wallwiener D; Pantel K
Breast Cancer Res Treat; 2010 Nov; 124(2):403-12. PubMed ID: 20859679
[TBL] [Abstract][Full Text] [Related]
36. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
[TBL] [Abstract][Full Text] [Related]
37. A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer.
Politaki E; Agelaki S; Apostolaki S; Hatzidaki D; Strati A; Koinis F; Perraki M; Saloustrou G; Stoupis G; Kallergi G; Spiliotaki M; Skaltsi T; Lianidou E; Georgoulias V; Mavroudis D
Cell Physiol Biochem; 2017; 44(2):594-606. PubMed ID: 29161698
[TBL] [Abstract][Full Text] [Related]
38. Detection of circulating breast cancer cells by reverse transcriptase polymerase chain reaction (RT-PCR).
Hu XC; Chow LW
Eur J Surg Oncol; 2000 Sep; 26(6):530-5. PubMed ID: 11034801
[TBL] [Abstract][Full Text] [Related]
39. Comparison of three distinct methods for the detection of circulating tumor cells in colorectal cancer patients.
Gervasoni A; Sandri MT; Nascimbeni R; Zorzino L; Cassatella MC; Baglioni L; Panigara S; Gervasi M; Di Lorenzo D; Parolini O
Oncol Rep; 2011 Jun; 25(6):1669-703. PubMed ID: 21455578
[TBL] [Abstract][Full Text] [Related]
40. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.
Shen C; Hu L; Xia L; Li Y
Clin Biochem; 2009 Feb; 42(3):194-200. PubMed ID: 19022237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]